Bortezomib (Bortezomib)

**Product type:** Human Prescription Drug

**Active ingredient:** BORTEZOMIB

**Strength:** 2.5 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous; Subcutaneous

**Labeler:** Gland Pharma Limited

**Marketing category:** ANDA (ANDA219167)

**Pharmacologic class:** Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]